International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung AdenocarcinomaWilliam D. Travis, David Yankelewitz, Michael K. Gould et al.|Journal of Thoracic Oncology|2011Cited by 4.8k
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung CancerGiorgio V. Scagliotti, David R. Gandara, Purvish Parikh et al.|Journal of Clinical Oncology|2008Cited by 3.2k
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1Giuseppe Giaccone, David H. Johnson, Roy S. Herbst et al.|Journal of Clinical Oncology|2004Cited by 1.7k
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple MyelomaDavid H. Henry, Howard Yeh, Luís Costa et al.|Journal of Clinical Oncology|2011Cited by 1.3k
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III StudiesGiorgio V. Scagliotti, Frances A. Shepherd|The Oncologist|2009Cited by 692